This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of human prostasomes.
Prostate. 2003 Jul 1;56(2):150-61.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Identification and proteomic profiling of exosomes in human urine.
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13368-73. Epub 2004 Aug 23.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism.
J Immunol. 2005 Aug 15;175(4):2237-43.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.
Proteomics. 2006 Jan;6(1):153-71.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.
Proteomics. 2006 Jan;6(1):153-71.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.
Proteomics. 2006 Jan;6(1):153-71.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Exosomes with immune modulatory features are present in human breast milk.
J Immunol. 2007 Aug 1;179(3):1969-78.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Exosomes with immune modulatory features are present in human breast milk.
J Immunol. 2007 Aug 1;179(3):1969-78.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of microvesicles derived from human colorectal cancer cells.
J Proteome Res. 2007 Dec;6(12):4646-55. Epub 2007 Oct 24.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311The proteome of red cell membranes and vesicles during storage in blood bank conditions.
Transfusion. 2008 May;48(5):827-35.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Isolation and identification of potential urinary microparticle biomarkers of bladder cancer.
J Proteome Res. 2008 May;7(5):2088-96. doi: 10.1021/pr700775x. Epub 2008 Mar 29.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Isolation and identification of potential urinary microparticle biomarkers of bladder cancer.
J Proteome Res. 2008 May;7(5):2088-96. doi: 10.1021/pr700775x. Epub 2008 Mar 29.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Protein composition of human epididymosomes collected during surgical vasectomy reversal: a proteomic and genomic approach.
Hum Reprod. 2008 Aug;23(8):1698-707. doi: 10.1093/humrep/den181. Epub 2008 May 14.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen.
Prostate. 2009 Feb 1;69(2):159-67. doi: 10.1002/pros.20860.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Large-scale proteomics and phosphoproteomics of urinary exosomes.
J Am Soc Nephrol. 2009 Feb;20(2):363-79. doi: 10.1681/ASN.2008040406. Epub 2008 Dec 3.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Characterization of PKD protein-positive exosome-like vesicles.
J Am Soc Nephrol. 2009 Feb;20(2):278-88. doi: 10.1681/ASN.2008060564. Epub 2009 Jan 21.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).
J Proteome Res. 2009 Mar;8(3):1304-14. doi: 10.1021/pr800658c.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures.
Blood. 2009 Jul 16;114(3):723-32. doi: 10.1182/blood-2009-02-205930. Epub 2009 Apr 15.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis.
J Proteome Res. 2009 Jul;8(7):3346-54. doi: 10.1021/pr801102c.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis.
J Proteome Res. 2009 Jul;8(7):3346-54. doi: 10.1021/pr801102c.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis.
J Proteome Res. 2009 Jul;8(7):3346-54. doi: 10.1021/pr801102c.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes.
J Cell Physiol. 2009 Oct;221(1):221-31. doi: 10.1002/jcp.21847.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes.
J Cell Physiol. 2009 Oct;221(1):221-31. doi: 10.1002/jcp.21847.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Differential stimulation of monocytic cells results in distinct populations of microparticles.
J Thromb Haemost. 2009 Jun;7(6):1019-28. doi: 10.1111/j.1538-7836.2009.03434.x.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Differential stimulation of monocytic cells results in distinct populations of microparticles.
J Thromb Haemost. 2009 Jun;7(6):1019-28. doi: 10.1111/j.1538-7836.2009.03434.x.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Differential stimulation of monocytic cells results in distinct populations of microparticles.
J Thromb Haemost. 2009 Jun;7(6):1019-28. doi: 10.1111/j.1538-7836.2009.03434.x.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Differential stimulation of monocytic cells results in distinct populations of microparticles.
J Thromb Haemost. 2009 Jun;7(6):1019-28. doi: 10.1111/j.1538-7836.2009.03434.x.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells.
Mol Cell Proteomics. 2009 Oct;8(10):2201-11. doi: 10.1074/mcp.M900203-MCP200. Epub 2009 Jun 29.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques.
Circ Cardiovasc Genet. 2009 Aug;2(4):379-88. doi: 10.1161/CIRCGENETICS.108.842849. Epub 2009 May 14.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomics analysis of bladder cancer exosomes.
Mol Cell Proteomics. 2010 Jun;9(6):1324-38. doi: 10.1074/mcp.M000063-MCP201. Epub 2010 Mar 11.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.
Immunol Cell Biol. 2010 Nov-Dec;88(8):851-6. doi: 10.1038/icb.2010.64. Epub 2010 May 11.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Microfiltration isolation of human urinary exosomes for characterization by MS.
Proteomics Clin Appl. 2010 Jan;4(1):84-96. doi: 10.1002/prca.200800093. Epub 2009 Nov 11.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells.
Exp Cell Res. 2011 May 1;317(8):1192-202. doi: 10.1016/j.yexcr.2011.01.014. Epub 2011 Jan 26.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Protein profile of exosomes from trabecular meshwork cells.
J Proteomics. 2011 May 16;74(6):796-804. doi: 10.1016/j.jprot.2011.02.024. Epub 2011 Mar 8.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways.
Mol Cell Proteomics. 2012 Feb;11(2):M111.012245. doi: 10.1074/mcp.M111.012245. Epub 2011 Oct 26.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311The protein interaction network of extracellular vesicles derived from human colorectal cancer cells.
J Proteome Res. 2012 Feb 3;11(2):1144-51. doi: 10.1021/pr200842h. Epub 2012 Jan 9.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
Methods. 2012 Feb;56(2):293-304. doi: 10.1016/j.ymeth.2012.01.002. Epub 2012 Jan 21.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
Methods. 2012 Feb;56(2):293-304. doi: 10.1016/j.ymeth.2012.01.002. Epub 2012 Jan 21.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
Methods. 2012 Feb;56(2):293-304. doi: 10.1016/j.ymeth.2012.01.002. Epub 2012 Jan 21.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes.
Kidney Int. 2012 Jun;81(12):1263-72. doi: 10.1038/ki.2012.25. Epub 2012 Mar 14.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes.
Kidney Int. 2012 Jun;81(12):1263-72. doi: 10.1038/ki.2012.25. Epub 2012 Mar 14.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of microvesicles released by the human prostate cancer cell line PC-3.
Mol Cell Proteomics. 2012 Jul;11(7):M111.012914. doi: 10.1074/mcp.M111.012914. Epub 2012 Mar 28.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311The proteome of erythrocyte-derived microparticles from plasma: new clues for erythrocyte aging and vesiculation.
J Proteomics. 2012 Dec 5;76 Spec No.:203-10. doi: 10.1016/j.jprot.2012.05.031. Epub 2012 Jun 2.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages.
J Immunol. 2012 Jul 15;189(2):744-54. doi: 10.4049/jimmunol.1102244. Epub 2012 Jun 18.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Restoration of full-length APC protein in SW480 colon cancer cells induces exosome-mediated secretion of DKK-4.
Electrophoresis. 2012 Jul;33(12):1873-80. doi: 10.1002/elps.201100687.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells.
Proteomics. 2012 Jul;12(13):2203-11. doi: 10.1002/pmic.201100376.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells.
Proteomics. 2012 Jul;12(13):2203-11. doi: 10.1002/pmic.201100376.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment.
PLoS One. 2012;7(7):e37279. doi: 10.1371/journal.pone.0037279. Epub 2012 Jul 12.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome.
Int J Proteomics. 2012;2012:971907. doi: 10.1155/2012/971907. Epub 2012 Jul 18.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts.
J Proteomics. 2012 Dec 21;77:344-56. doi: 10.1016/j.jprot.2012.09.008. Epub 2012 Sep 20.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts.
J Proteomics. 2012 Dec 21;77:344-56. doi: 10.1016/j.jprot.2012.09.008. Epub 2012 Sep 20.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases.
PLoS One. 2012;7(11):e49726. doi: 10.1371/journal.pone.0049726. Epub 2012 Nov 20.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases.
PLoS One. 2012;7(11):e49726. doi: 10.1371/journal.pone.0049726. Epub 2012 Nov 20.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases.
PLoS One. 2012;7(11):e49726. doi: 10.1371/journal.pone.0049726. Epub 2012 Nov 20.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.
J Proteomics. 2013 Apr 26;82:193-229. doi: 10.1016/j.jprot.2013.01.012. Epub 2013 Jan 30.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Differential protein profiling of renal cell carcinoma urinary exosomes.
Mol Biosyst. 2013 Jun;9(6):1220-33. doi: 10.1039/c3mb25582d. Epub 2013 Mar 19.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Differential protein profiling of renal cell carcinoma urinary exosomes.
Mol Biosyst. 2013 Jun;9(6):1220-33. doi: 10.1039/c3mb25582d. Epub 2013 Mar 19.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Proteomics. 2013 May;13(10-11):1672-86. doi: 10.1002/pmic.201200562.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Proteomics. 2013 May;13(10-11):1672-86. doi: 10.1002/pmic.201200562.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition.
Mol Cell Proteomics. 2013 Aug;12(8):2148-59. doi: 10.1074/mcp.M112.027086. Epub 2013 May 3.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition.
Mol Cell Proteomics. 2013 Aug;12(8):2148-59. doi: 10.1074/mcp.M112.027086. Epub 2013 May 3.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Modulation of B-cell exosome proteins by gamma herpesvirus infection.
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2925-33. doi: 10.1073/pnas.1303906110. Epub 2013 Jul 1.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Characterization of human thymic exosomes.
PLoS One. 2013 Jul 2;8(7):e67554. doi: 10.1371/journal.pone.0067554. Print 2013.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311LRRK2 secretion in exosomes is regulated by 14-3-3.
Hum Mol Genet. 2013 Dec 15;22(24):4988-5000. doi: 10.1093/hmg/ddt346. Epub 2013 Jul 25.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Characterization of multiple myeloma vesicles by label-free relative quantitation.
Proteomics. 2013 Oct;13(20):3013-29. doi: 10.1002/pmic.201300142.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Characterization of multiple myeloma vesicles by label-free relative quantitation.
Proteomics. 2013 Oct;13(20):3013-29. doi: 10.1002/pmic.201300142.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18396. eCollection 2012.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression.
PLoS One. 2013 Sep 19;8(9):e75054. doi: 10.1371/journal.pone.0075054. eCollection 2013.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
J Proteomics. 2014 Jan 16;96:92-102. doi: 10.1016/j.jprot.2013.10.037. Epub 2013 Nov 7.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
J Proteomics. 2014 Jan 16;96:92-102. doi: 10.1016/j.jprot.2013.10.037. Epub 2013 Nov 7.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
PLoS One. 2013 Dec 31;8(12):e82589. doi: 10.1371/journal.pone.0082589. eCollection 2013.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
PLoS One. 2013 Dec 31;8(12):e82589. doi: 10.1371/journal.pone.0082589. eCollection 2013.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
PLoS One. 2013 Dec 31;8(12):e82589. doi: 10.1371/journal.pone.0082589. eCollection 2013.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
PLoS One. 2013 Dec 31;8(12):e82589. doi: 10.1371/journal.pone.0082589. eCollection 2013.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311Exosomal proteins in the aqueous humor as novel biomarkers in patients with neovascular age-related macular degeneration.
J Proteome Res. 2014 Feb 7;13(2):581-95. doi: 10.1021/pr400751k. Epub 2014 Jan 16.
ENOG410XQFP502 / 0 / 502
Ezrin (Cytovillin) (Villin-2) (p81)P15311In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.
ENOG410XQFP502 / 0 / 502
[1] [2] [3] [4]